The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Guanylate cyclase c (GUCY2C) as a preventative and therapeutic target in colorectal cancers (CRCs) arising through divergent genomic pathways.
 
Babar Bashir
No Relationships to Disclose
 
Dante Merlino
No Relationships to Disclose
 
Jeffrey Rappaport
No Relationships to Disclose
 
Esteban D Gnass
No Relationships to Disclose
 
Juan Palazzo
No Relationships to Disclose
 
Yeng Fing
No Relationships to Disclose
 
Eric R Fearon
No Relationships to Disclose
 
Adam Snook
Honoraria - Dava Oncology
Research Funding - Advaxis; Targeted Diagnostics & Therapeutics
Patents, Royalties, Other Intellectual Property - Targeted Diagnostics & Therapeutics
 
Scott A Waldman
Leadership - Feelux
Honoraria - Synergy Pharmateuticals
Consulting or Advisory Role - Synergy Pharmateuticals
Speakers' Bureau - Synergy Pharmateuticals
Research Funding - Synergy Pharmateuticals; Targeted Diagnostics & Therapeutics
Patents, Royalties, Other Intellectual Property - Thomas Jefferson University
Travel, Accommodations, Expenses - Synergy Pharmateuticals